Fintel reports that on January 8, 2025, RBC Capital upgraded their outlook for Phreesia (NYSE:PHR) from Sector Perform to Outperform.
Analyst Price Forecast Suggests 8.40% Upside
As of December 24, 2024, the average one-year price target for Phreesia is $30.82/share. The forecasts range from a low of $24.24 to a high of $37.80. The average price target represents an increase of 8.40% from its latest reported closing price of $28.43 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Phreesia is 461MM, an increase of 13.87%. The projected annual non-GAAP EPS is -0.77.
What is the Fund Sentiment?
There are 411 funds or institutions reporting positions in Phreesia. This is an increase of 11 owner(s) or 2.75% in the last quarter. Average portfolio weight of all funds dedicated to PHR is 0.15%, an increase of 7.77%. Total shares owned by institutions increased in the last three months by 2.41% to 69,221K shares. 
The put/call ratio of PHR is 0.76, indicating a bullish outlook.
What are Other Shareholders Doing?
Brown Advisory holds 5,686K shares representing 9.78% ownership of the company. In its prior filing, the firm reported owning 5,768K shares , representing a decrease of 1.44%. The firm decreased its portfolio allocation in PHR by 57.39% over the last quarter.
Capital International Investors holds 2,593K shares representing 4.46% ownership of the company. No change in the last quarter.
SMCWX - SMALLCAP WORLD FUND INC holds 2,593K shares representing 4.46% ownership of the company. No change in the last quarter.
Champlain Investment Partners holds 2,504K shares representing 4.31% ownership of the company. In its prior filing, the firm reported owning 2,406K shares , representing an increase of 3.91%. The firm increased its portfolio allocation in PHR by 10.28% over the last quarter.
Rock Springs Capital Management holds 2,282K shares representing 3.93% ownership of the company. In its prior filing, the firm reported owning 2,418K shares , representing a decrease of 5.91%. The firm increased its portfolio allocation in PHR by 9.71% over the last quarter.
Phreesia Background Information
(This description is provided by the company.)
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimize their staffing, boost profitability and enhance clinical care.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
